This compound is primarily used in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. It serves as an intermediate in the preparation of biologically active molecules, especially those targeting neurological and oncological disorders. Its structure, featuring both fluorine and iodine atoms, makes it valuable in the design of compounds for positron emission tomography (PET) imaging, aiding in the study of disease mechanisms and drug distribution in the body. Additionally, it is explored in medicinal chemistry for its potential role in developing inhibitors for specific enzymes or receptors involved in disease pathways.